Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
The primary endpoint of the BETonMACE trial is time to first occurence of strict 3-point major adverse cardiac events (MACE): cardiovascular death, non-fatal myocardial infarction, non-fatal stroke. Those are cardiovascular outcomes. Since the finalization of trial design last year, BETonMACE has always been a cardiovascular outcomes trial (CVOT).
